[go: up one dir, main page]

MX2008010233A - Composicion de liberacion modificada, que comprende doxofilina. - Google Patents

Composicion de liberacion modificada, que comprende doxofilina.

Info

Publication number
MX2008010233A
MX2008010233A MX2008010233A MX2008010233A MX2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A
Authority
MX
Mexico
Prior art keywords
doxofylline
modified release
release composition
pharmaceutically
derivative
Prior art date
Application number
MX2008010233A
Other languages
English (en)
Inventor
Frederick Van Gulik
Madhusudan Rao Yamsani
Ramesh Gannu
Suresh Bandari
Bodapunti Prabha Shakar
Original Assignee
Eurodrug Lab B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Lab B V filed Critical Eurodrug Lab B V
Publication of MX2008010233A publication Critical patent/MX2008010233A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Photolithography (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención concierne a una composición de liberación modificada, basada en doxofilina, para administración solamente una vez al día.
MX2008010233A 2008-03-10 2008-03-10 Composicion de liberacion modificada, que comprende doxofilina. MX2008010233A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/000554 WO2009112874A1 (en) 2008-03-10 2008-03-10 Modified release composition comprising doxofylline

Publications (1)

Publication Number Publication Date
MX2008010233A true MX2008010233A (es) 2009-11-10

Family

ID=40084194

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008010233A MX2008010233A (es) 2008-03-10 2008-03-10 Composicion de liberacion modificada, que comprende doxofilina.
MX2010009917A MX2010009917A (es) 2008-03-10 2009-03-06 Composicion de liberacion modificada que comprende doxofilina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010009917A MX2010009917A (es) 2008-03-10 2009-03-06 Composicion de liberacion modificada que comprende doxofilina.

Country Status (7)

Country Link
EP (1) EP2262485A1 (es)
KR (1) KR101697773B1 (es)
AU (1) AU2009224801B2 (es)
BR (1) BRPI0906158B8 (es)
IT (1) ITMI20080798A1 (es)
MX (2) MX2008010233A (es)
WO (2) WO2009112874A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150063040A (ko) * 2012-09-26 2015-06-08 유로드러그 레버러토리즈 비. 브이. 간 질환의 치료에 사용하기 위한 메타독신 및 메타독신 연장 방출성 제제
CN103524503B (zh) * 2013-10-29 2014-08-06 天津梅花医药有限公司 多索茶碱半水化合物
CN110898019A (zh) * 2019-12-19 2020-03-24 上海宣泰海门药业有限公司 多索茶碱片及其制备方法
CN119909028B (zh) * 2025-01-21 2025-10-14 福安药业集团宁波天衡制药有限公司 一种多索茶碱片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
PT797987E (pt) * 1994-12-19 2004-02-27 Daiichi Seiyaku Co Preparacao granular de libertacao controlada e processo para a sua preparacao
US20040087653A1 (en) * 2002-05-16 2004-05-06 Manning Pamela T. Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor
JP4792974B2 (ja) * 2003-12-25 2011-10-12 小野薬品工業株式会社 アゼチジン環化合物およびその医薬
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
ES2366375T3 (es) * 2005-02-22 2011-10-19 Pfizer, Inc. Derivados de oxiindol, como agonistas del receptor 5-ht4.
WO2007120485A2 (en) * 2006-03-30 2007-10-25 Cinergen, Llc Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
CN100536849C (zh) * 2006-05-10 2009-09-09 鲁南制药集团股份有限公司 含有茶碱类药物和维生素k的药物组合物
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
CN101028254B (zh) * 2007-04-05 2010-05-19 合肥合源医药科技股份有限公司 一种多索茶碱缓释制剂及其制备方法

Also Published As

Publication number Publication date
BRPI0906158B1 (pt) 2021-01-05
BRPI0906158B8 (pt) 2021-05-25
MX2010009917A (es) 2010-12-21
ITMI20080798A1 (it) 2009-09-11
AU2009224801A1 (en) 2009-09-17
AU2009224801B2 (en) 2014-06-05
EP2262485A1 (en) 2010-12-22
BRPI0906158A2 (pt) 2017-07-18
KR101697773B1 (ko) 2017-01-18
WO2009112874A1 (en) 2009-09-17
KR20100124860A (ko) 2010-11-30
WO2009112436A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
JO3757B1 (ar) التركيبات الصيدلانية التي تشمل على نيلوتينيب أو أملاحه
SG169353A1 (en) Tamper resistant dosage forms
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
MX343358B (es) Tabletas de acetato de ulipristal.
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
AP2011005687A0 (en) Sustained release drug delivery system.
MY144857A (en) Phamaceutical composition comprising amlodipine and losartan
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2009071690A3 (de) 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2010038237A3 (en) Compositions exhibiting delayed transit through the gastrointestinal tract
TR200904159A1 (tr) Değiştirilmiş salım sağlayan emoksipin formülasyonları.
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
MX2008010233A (es) Composicion de liberacion modificada, que comprende doxofilina.
EA201390603A1 (ru) Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
EP2292241A4 (en) SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE
TW200833359A (en) Elution-improved pharmaceutical preparation
IL195618A0 (en) Drug administration methods
WO2007093168A3 (de) Schnell freisetzende irbesartan-haltige pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
FG Grant or registration